Vivisol, the home healthcare subsidiary of Italian gases group SOL SpA, is now a leading provider in Europe, and has been clocking in at around 70% of group EBIT. That makes the shares one of the purest European plays on the growing trend for health authorities to de-hospitalize parts of in-patient care.
